Pathophysiology of the no-reflow phenomenon

Area of Science:

• Cardiology
• Vascular Biology
• Pathophysiology

Background:

• The no-reflow phenomenon complicates primary percutaneous coronary intervention (PCI) in acute ST-segment elevation myocardial infarction (STEMI), affecting approximately one-third of patients.
• Microvascular damage in the infarct-related artery's perfusion territory results from prolonged ischemia and reperfusion injury.
• Reperfusion injury involves oxidative stress and the energy paradox, leading to endothelial cell and cardiomyocyte damage.

Purpose of the Study:

• To explore the expanded understanding of the pathophysiology of the no-reflow phenomenon.
• To identify mechanisms contributing to microvascular obstruction during reperfusion.
• To highlight novel therapeutic approaches based on new pathophysiological insights.

Main Methods:

• Review of current understanding of no-reflow pathophysiology.
• Analysis of contributing factors including ischemia, reperfusion injury, oxidative stress, endothelial dysfunction, and iatrogenic embolization.
• Discussion of emerging therapeutic strategies.

Main Results:

• Microvascular obstruction is caused by reperfusion injury (vasoconstriction, capillary plugging, edema) and embolization of thrombus/plaque.
• Oxidative stress and the energy paradox are key drivers of lethal reperfusion injury.
• Endothelial dysfunction, neutrophil infiltration, and myocardial edema exacerbate microvascular plugging.

Conclusions:

• Understanding no-reflow pathophysiology has advanced, implicating both ischemia and reperfusion injury.
• Therapeutic strategies include preventing embolization via thrombus aspiration and reducing reperfusion injury with post-conditioning.
• New insights offer potential for improved management of no-reflow during primary PCI for STEMI.